Asthma is a respiratory condition, where the airways become
inflamed and narrow, which can cause a serious and incurable condition if left
untreated. Breathlessness, wheezing and coughing are some of the symptoms of
asthma and it can be controlled by avoiding triggers and with the help of drug
therapy. Environmental triggers may vary from consumer to consumer but it can include
exercise, smoke, cold air and other allergens such as pollen, dust mites, and
infections. The wheezing in asthma begins when the chemicals present in the
lungs overreact to the dust mites, cold air and exercise.
According to Centers for Disease Control and Prevention
(CDC), asthma is an ordinary chronic airway disorder which is characterized by
swelling of air passages that convey air from mouth and nose to lungs. Asthma
is caused generally due to allergies leading to inflammation of lungs.
GlaxoSmithKline Pharmaceuticals Limited and Novartis AG are
developing once-a-day combination products that are longer acting than
currently available drugs and more suitable for patients due to its advantage
of being taken only once a day.
Request to Get the Sample Pages at: 
Based on drug class, the global asthma market can be
categorized bronchodilators, combination therapies, mast cell stabilizers,
leukotriene antagonists and immunosuppressants. On the basis of route of
administration, the global market is segmented into oral, inhaled and other
route of administrations.
Make
Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=asthma-market
Daily exposure to hazardous working environment, influx
of pollutants in the air, increase in population susceptible to indoor air
pollutants, increase in disposable income, increasing population of smokers,
improved healthcare facility, and growing aging population are some of other
the major factors that are driving the growth of asthma market. Factors that
are restraining the growth of asthma market are high cost of asthma treatment,
patent expiry of many best-seller brands and long treatment continuation.
Additionally, lack of diagnostic tools for reliable asthma diagnosis in young
children is also limiting the growth of global asthma market.
Some of the major competitors of global asthma market
are, Ono Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Teva Pharmaceutical
Industries Ltd. Merck & Co., Inc., Astrazeneca plc, Sunovion
Pharmaceuticals, Inc., Novartis AG, Boehringer Ingelheim GmbH, Koninklijke
Philips N.V., and F. Hoffmann La-Roche Ltd.
About P&S
Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider
of market research and consulting services catering to the market information
needs of burgeoning industries across the world. Providing the plinth of market
intelligence, P&S as an enterprising research and consulting company,
believes in providing thorough landscape analyses on the ever-changing market
scenario, to empower companies to make informed decisions and base their
business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886
(USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
